Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPTX |
---|---|---|
09:32 ET | 3736 | 3.44 |
09:34 ET | 6984 | 3.435 |
09:36 ET | 3000 | 3.4549 |
09:38 ET | 14579 | 3.475 |
09:39 ET | 6411 | 3.535 |
09:41 ET | 500 | 3.5225 |
09:43 ET | 1926 | 3.59 |
09:45 ET | 600 | 3.58 |
09:48 ET | 300 | 3.52 |
09:52 ET | 300 | 3.49 |
09:54 ET | 145 | 3.4971 |
09:56 ET | 300 | 3.47 |
09:57 ET | 200 | 3.475 |
10:01 ET | 300 | 3.41 |
10:03 ET | 100 | 3.44 |
10:08 ET | 1713 | 3.47 |
10:10 ET | 1200 | 3.52 |
10:14 ET | 301 | 3.49 |
10:15 ET | 900 | 3.495 |
10:17 ET | 509 | 3.5199 |
10:19 ET | 100 | 3.48 |
10:24 ET | 648 | 3.53 |
10:26 ET | 1550 | 3.565 |
10:30 ET | 100 | 3.565 |
10:35 ET | 11656 | 3.48 |
10:37 ET | 8501 | 3.48 |
10:42 ET | 3179 | 3.56 |
10:44 ET | 1500 | 3.55 |
10:48 ET | 195 | 3.58 |
10:50 ET | 100 | 3.56 |
11:02 ET | 100 | 3.53 |
11:04 ET | 400 | 3.53 |
11:06 ET | 100 | 3.52 |
11:08 ET | 142 | 3.5499 |
11:11 ET | 500 | 3.5201 |
11:13 ET | 100 | 3.52 |
11:18 ET | 400 | 3.51 |
11:20 ET | 958 | 3.525 |
11:26 ET | 100 | 3.5113 |
11:33 ET | 500 | 3.5 |
11:38 ET | 7909 | 3.47 |
11:40 ET | 200 | 3.455 |
11:42 ET | 329 | 3.46 |
11:54 ET | 135 | 3.46 |
11:56 ET | 300 | 3.46 |
12:05 ET | 700 | 3.445 |
12:09 ET | 100 | 3.445 |
12:16 ET | 100 | 3.43 |
12:20 ET | 200 | 3.4451 |
12:21 ET | 875 | 3.4797 |
12:27 ET | 1000 | 3.48 |
12:36 ET | 300 | 3.48 |
12:45 ET | 200 | 3.485 |
12:48 ET | 200 | 3.485 |
12:54 ET | 200 | 3.47 |
12:56 ET | 100 | 3.47 |
01:01 ET | 800 | 3.47 |
01:14 ET | 3202 | 3.52 |
01:15 ET | 100 | 3.4801 |
01:21 ET | 250 | 3.53 |
01:26 ET | 248 | 3.5676 |
01:37 ET | 100 | 3.58 |
01:39 ET | 600 | 3.5401 |
01:42 ET | 200 | 3.57 |
01:46 ET | 100 | 3.544 |
01:48 ET | 100 | 3.5435 |
01:53 ET | 1200 | 3.53 |
01:57 ET | 294 | 3.5463 |
02:00 ET | 5830 | 3.5 |
02:04 ET | 100 | 3.51 |
02:06 ET | 1117 | 3.52 |
02:08 ET | 384 | 3.54 |
02:09 ET | 300 | 3.54 |
02:11 ET | 435 | 3.535 |
02:18 ET | 300 | 3.55 |
02:22 ET | 100 | 3.54 |
02:24 ET | 250 | 3.5229 |
02:29 ET | 100 | 3.5372 |
02:31 ET | 400 | 3.56 |
02:42 ET | 100 | 3.56 |
02:49 ET | 400 | 3.49 |
02:51 ET | 541 | 3.52 |
02:54 ET | 700 | 3.505 |
02:56 ET | 1120 | 3.52 |
03:02 ET | 1327 | 3.51 |
03:03 ET | 200 | 3.51 |
03:05 ET | 1105 | 3.495 |
03:07 ET | 2395 | 3.5399 |
03:09 ET | 1400 | 3.525 |
03:14 ET | 100 | 3.53 |
03:25 ET | 2298 | 3.57 |
03:32 ET | 900 | 3.54 |
03:34 ET | 1000 | 3.5579 |
03:39 ET | 1000 | 3.5492 |
03:41 ET | 100 | 3.5599 |
03:43 ET | 3471 | 3.55 |
03:45 ET | 900 | 3.53 |
03:48 ET | 1700 | 3.51 |
03:50 ET | 1500 | 3.505 |
03:52 ET | 1654 | 3.49 |
03:54 ET | 611 | 3.48 |
03:56 ET | 2600 | 3.45 |
03:57 ET | 3737 | 3.47 |
03:59 ET | 3200 | 3.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Repare Therapeutics Inc | 142.2M | -3.2x | --- |
Precision BioSciences Inc | 88.8M | -2.3x | --- |
Champions Oncology Inc | 61.2M | -6.3x | --- |
AVITA Medical Inc | 239.9M | -5.5x | --- |
MEI Pharma Inc | 19.3M | 0.7x | --- |
Metagenomi Inc | 239.4M | -3.5x | --- |
Repare Therapeutics Inc. is a clinical-stage precision oncology company focused on the development of synthetic lethality (SL)-based therapies for patients with cancer. The Company is engaged in the proprietary SL approach to the discovery and development of novel therapeutics. It uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. The Company’s initial product candidate, camonsertib (RP-3500 or RG6526), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations, including those in the ataxia telangiectasia mutated kinase (ATM) gene as part of a network of 16 STEP2-identified genomic alterations. Its other pipeline includes Lunresertib PKMYT1 Inhibitor and RP-3467 polymerase theta (Pol0) Inhibitor.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $142.2M |
---|---|
Revenue (TTM) | $97.9M |
Shares Outstanding | 42.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-1.10 |
Book Value | $5.03 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.